161 related articles for article (PubMed ID: 22354306)
1. Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses.
Sobottka I; Wegscheider K; Balzer L; Böger RH; Hallier O; Giersdorf I; Streichert T; Haddad M; Platzer U; Cachovan G
Antimicrob Agents Chemother; 2012 May; 56(5):2565-9. PubMed ID: 22354306
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.
Sobottka I; Cachovan G; Stürenburg E; Ahlers MO; Laufs R; Platzer U; Mack D
Antimicrob Agents Chemother; 2002 Dec; 46(12):4019-21. PubMed ID: 12435716
[TBL] [Abstract][Full Text] [Related]
3. Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study.
Al-Nawas B; Walter C; Morbach T; Seitner N; Siegel E; Maeurer M; Krummenauer F
Eur J Clin Microbiol Infect Dis; 2009 Jan; 28(1):75-82. PubMed ID: 18663500
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.
Cachovan G; Böger RH; Giersdorf I; Hallier O; Streichert T; Haddad M; Platzer U; Schön G; Wegscheider K; Sobottka I
Antimicrob Agents Chemother; 2011 Mar; 55(3):1142-7. PubMed ID: 21173173
[TBL] [Abstract][Full Text] [Related]
5. Radiography-based score indicative for the pathogenicity of bacteria in odontogenic infections.
Cachovan G; Blessmann M; Schön G; Rother U; Heiland M; Stürenburg E; Platzer U; Sobottka I
Acta Odontol Scand; 2014 Oct; 72(7):530-6. PubMed ID: 24444257
[TBL] [Abstract][Full Text] [Related]
6. Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses.
Warnke PH; Becker ST; Springer IN; Haerle F; Ullmann U; Russo PA; Wiltfang J; Fickenscher H; Schubert S
J Craniomaxillofac Surg; 2008 Dec; 36(8):462-7. PubMed ID: 18760616
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.
Diz Dios P; Tomás Carmona I; Limeres Posse J; Medina Henríquez J; Fernández Feijoo J; Alvarez Fernández M
Antimicrob Agents Chemother; 2006 Sep; 50(9):2996-3002. PubMed ID: 16940094
[TBL] [Abstract][Full Text] [Related]
8. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections.
Kuriyama T; Karasawa T; Nakagawa K; Saiki Y; Yamamoto E; Nakamura S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):600-8. PubMed ID: 11077383
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Malangoni MA; Song J; Herrington J; Choudhri S; Pertel P
Ann Surg; 2006 Aug; 244(2):204-11. PubMed ID: 16858182
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.
Schaper NC; Dryden M; Kujath P; Nathwani D; Arvis P; Reimnitz P; Alder J; Gyssens IC
Infection; 2013 Feb; 41(1):175-86. PubMed ID: 23180507
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.
Gyssens IC; Dryden M; Kujath P; Nathwani D; Schaper N; Hampel B; Reimnitz P; Alder J; Arvis P
J Antimicrob Chemother; 2011 Nov; 66(11):2632-42. PubMed ID: 21896561
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology].
Isla A; Canut A; Rodríguez-Gascón A; Labora A; Ardanza-Trevijano B; Solinís MA; Pedraz JL
Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):116-21. PubMed ID: 15757581
[TBL] [Abstract][Full Text] [Related]
13. [Bacterial spectra and antibiotics in odontogenic infections. Renaissance of the penicillins?].
Eckert AW; Maurer P; Wilhelms D; Schubert J
Mund Kiefer Gesichtschir; 2005 Nov; 9(6):377-83. PubMed ID: 16261393
[TBL] [Abstract][Full Text] [Related]
14. Controversies in antibiotic choices for odontogenic infections.
Stefanopoulos PK; Kolokotronis AE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):697-8. PubMed ID: 16731384
[No Abstract] [Full Text] [Related]
15. Bacteriological findings and antimicrobial resistance in odontogenic and non-odontogenic chronic maxillary sinusitis.
Puglisi S; Privitera S; Maiolino L; Serra A; Garotta M; Blandino G; Speciale A
J Med Microbiol; 2011 Sep; 60(Pt 9):1353-1359. PubMed ID: 21498651
[TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Alder J; Haverstock D; Trajanovic M; Sethi S
Eur Respir J; 2012 Jul; 40(1):17-27. PubMed ID: 22135277
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections.
Edmiston CE; Krepel CJ; Seabrook GR; Somberg LR; Nakeeb A; Cambria RA; Towne JB
Antimicrob Agents Chemother; 2004 Mar; 48(3):1012-6. PubMed ID: 14982797
[TBL] [Abstract][Full Text] [Related]
18. Clindamycin versus Unasyn in the treatment of facial cellulitis of odontogenic origin in children.
Rush DE; Abdel-Haq N; Zhu JF; Aamar B; Malian M
Clin Pediatr (Phila); 2007 Mar; 46(2):154-9. PubMed ID: 17325089
[TBL] [Abstract][Full Text] [Related]
19. Severe versus local odontogenic bacterial infections: comparison of microbial isolates.
Al-Nawas B; Maeurer M
Eur Surg Res; 2008; 40(2):220-4. PubMed ID: 17998782
[TBL] [Abstract][Full Text] [Related]
20. Patients' perception of recovery after third molar surgery following postoperative treatment with moxifloxacin versus amoxicillin and clavulanic acid: a randomized, double-blind, controlled study.
Limeres J; Sanromán JF; Tomás I; Diz P
J Oral Maxillofac Surg; 2009 Feb; 67(2):286-91. PubMed ID: 19138601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
